CYCLIC AMP BINDING PROTEINS AND RAS FUNCTION

Information

  • Research Project
  • 3503439
  • ApplicationId
    3503439
  • Core Project Number
    R43MH050942
  • Full Project Number
    1R43MH050942-01
  • Serial Number
    50942
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1992 - 32 years ago
  • Project End Date
    3/31/1993 - 31 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1992 - 32 years ago
  • Budget End Date
    3/31/1993 - 31 years ago
  • Fiscal Year
    1992
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/25/1992 - 32 years ago

CYCLIC AMP BINDING PROTEINS AND RAS FUNCTION

Two CAMP binding proteins (50k and 10k daltons) that alter biochemical properties of protooncogene Ras in a CAMP dependent manner were isolated from bovine brain. In the presence of CAMP, the 50K dalton protein (p50) inhibited the nucleotide exchange reaction of Ras, whereas the 10K protein (p10) inhibited nucleotide binding. In the absence of cAMP, these two proteins are totally inactive. It is well established that protooncogene Ras plays an important role in controlling cell proliferation and differentiation. The interaction between these two proteins and Ras may represent a novel mechanism by which cell proliferation and differentiation are regulated. The objective of this phase I proposal is to partially purify these two proteins, established a standard assay and screen for the compounds or natural products that are able to alter the biochemical and biological activity of these two proteins. The compounds identified in this phase I study may develop into potential anti-proliferative drugs. In the phase II portion of this grant, these two proteins will be purified, sequenced and cloned. The biological significance of these two proteins will be elucidated by introducing these two proteins into cultured cells by protein microinjection and/or gene transfer techniques. Alternatively, antibodies that are able to neutralize these two proteins will be microinjected into cultured cells to determine the biological function of these two proteins. The cell model will be established to screen the compounds that are able to alter the biological activity of these two proteins.

IC Name
NATIONAL INSTITUTE OF MENTAL HEALTH
  • Activity
    R43
  • Administering IC
    MH
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    SPHINX PHARMACEUTICALS CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    DURHAM
  • Organization State
    NC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    27717
  • Organization District
    UNITED STATES